Catherine Fortpied

4.5k total citations
52 papers, 1.0k citations indexed

About

Catherine Fortpied is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Pathology and Forensic Medicine. According to data from OpenAlex, Catherine Fortpied has authored 52 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 21 papers in Otorhinolaryngology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Catherine Fortpied's work include Lung Cancer Treatments and Mutations (22 papers), Head and Neck Cancer Studies (21 papers) and Lymphoma Diagnosis and Treatment (19 papers). Catherine Fortpied is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Head and Neck Cancer Studies (21 papers) and Lymphoma Diagnosis and Treatment (19 papers). Catherine Fortpied collaborates with scholars based in Belgium, Netherlands and France. Catherine Fortpied's co-authors include Alexander Ring, Björn Penninckx, Ulrich Wedding, Pierre Scalliet, S. Monfardini, Denis Lacombe, Hans Wildiers, Paul Janssen, Iva Kezic and Luc Duchateau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Catherine Fortpied

47 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Fortpied Belgium 16 405 328 291 162 154 52 1.0k
Vanita Noronha India 16 456 1.1× 174 0.5× 404 1.4× 71 0.4× 83 0.5× 97 1.0k
V. Servent France 12 610 1.5× 173 0.5× 352 1.2× 300 1.9× 55 0.4× 30 1.2k
Noam A. VanderWalde United States 16 269 0.7× 62 0.2× 242 0.8× 149 0.9× 225 1.5× 48 822
Antonella Venturino Italy 14 533 1.3× 93 0.3× 279 1.0× 249 1.5× 25 0.2× 57 953
Camille Chakiba France 15 370 0.9× 101 0.3× 316 1.1× 167 1.0× 15 0.1× 35 798
Jean-Pierre Droz France 12 795 2.0× 103 0.3× 575 2.0× 520 3.2× 33 0.2× 12 2.0k
Belinda A. Campbell Australia 19 415 1.0× 521 1.6× 205 0.7× 13 0.1× 44 0.3× 72 1.1k
A. Brewster United Kingdom 16 587 1.4× 117 0.4× 499 1.7× 78 0.5× 41 0.3× 33 1.2k
Linda Coate Ireland 13 333 0.8× 76 0.2× 343 1.2× 66 0.4× 21 0.1× 36 756
J. L. Lagrange France 12 333 0.8× 97 0.3× 661 2.3× 57 0.4× 28 0.2× 44 1.1k

Countries citing papers authored by Catherine Fortpied

Since Specialization
Citations

This map shows the geographic impact of Catherine Fortpied's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Fortpied with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Fortpied more than expected).

Fields of papers citing papers by Catherine Fortpied

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Fortpied. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Fortpied. The network helps show where Catherine Fortpied may publish in the future.

Co-authorship network of co-authors of Catherine Fortpied

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Fortpied. A scholar is included among the top collaborators of Catherine Fortpied based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Fortpied. Catherine Fortpied is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zumsteg, Zachary S., Michael Luu, Catherine Fortpied, et al.. (2025). Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931. Annals of Oncology. 36(11). 1379–1388. 1 indexed citations
3.
Limkin, Elaine Johanna, Pierre Blanchard, Benjamin Lacas, et al.. (2023). Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses. Radiotherapy and Oncology. 190. 110011–110011. 1 indexed citations
4.
Loriot, Axelle, Nicolas D. Huyghe, Rose‐Marie Goebbels, et al.. (2023). Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111). Clinical Cancer Research. 29(20). 4076–4087.
5.
Aleman, Berthe M.P., Umberto Ricardi, Richard W.M. van der Maazen, et al.. (2023). A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned. International Journal of Radiation Oncology*Biology*Physics. 117(3). 664–674. 3 indexed citations
6.
7.
Vachon, Hugo, Madeline Pe, Corneel Coens, et al.. (2021). Reference values for the EORTC QLQ‐C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors. European Journal Of Haematology. 106(5). 697–707. 3 indexed citations
8.
Szturz, Petr, Éva Remenár, Carla M.L. van Herpen, et al.. (2021). Prognostic factor analysis and long-term results of the TAX 323 (EORTC 24971) study in unresectable head and neck cancer patients. European Journal of Cancer. 156. 109–118. 3 indexed citations
9.
Galot, Rachel, Christophe Le Tourneau, J. Guigay, et al.. (2018). Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach. Annals of Oncology. 29(12). 2313–2327. 48 indexed citations
10.
11.
Petit, Claire, Jean‐Pierre Pignon, C. Landais, et al.. (2017). What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups. European Journal of Cancer. 72. S101–S102. 3 indexed citations
12.
Maraldo, Maja V., Francesco Giusti, M. Henry‐Amar, et al.. (2017). Cardiac Disease and Lifestyle Risk Factors Following Hodgkin Lymphoma: An EORTC Lymphoma Group and GELA Follow-Up Study. International Journal of Radiation Oncology*Biology*Physics. 99(2). S139–S140. 1 indexed citations
13.
Eichenauer, Dennis A., Ingrid Becker, Ina Monsef, et al.. (2017). Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials. Haematologica. 102(10). 1748–1757. 29 indexed citations
14.
Specenier, Pol, Éva Remenár, Jan Buter, et al.. (2017). TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial. Annals of Oncology. 28(9). 2219–2224. 12 indexed citations
15.
Blanchard, Pierre, C. Landais, Claire Petit, et al.. (2016). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group. Annals of Oncology. 27. vi328–vi328. 25 indexed citations
16.
Maraldo, Maja V., Francesco Giusti, Ivan R. Vogelius, et al.. (2015). Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. The Lancet Haematology. 2(11). e492–e502. 110 indexed citations
17.
18.
Carde, Patrice, Matthias Karrasch, Catherine Fortpied, et al.. (2012). ABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup  randomized phase III clinical trial.. Journal of Clinical Oncology. 30(15_suppl). 8002–8002. 25 indexed citations
19.
Pallis, Athanasios, Alexander Ring, Catherine Fortpied, et al.. (2011). EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors. Annals of Oncology. 22(8). 1922–1926. 96 indexed citations
20.
Soubeyran, Pierre, Hussein Khaled, Marius MacKenzie, et al.. (2010). Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly. Journal of Geriatric Oncology. 2(1). 36–44. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanita Noronha Breakdown of academic impact, for papers by V. Servent Breakdown of academic impact, for papers by Noam A. VanderWalde Breakdown of academic impact, for papers by Antonella Venturino Breakdown of academic impact, for papers by Camille Chakiba Breakdown of academic impact, for papers by Jean-Pierre Droz Breakdown of academic impact, for papers by Belinda A. Campbell Breakdown of academic impact, for papers by A. Brewster Breakdown of academic impact, for papers by Linda Coate Breakdown of academic impact, for papers by J. L. Lagrange
Rankless by CCL
2026